InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by PIMSTONE SIMON N., Chief Executive Officer. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 6 reports have been recorded. Total volume traded: €1m. The latest transaction was filed on 8 March 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€70,8682,500 shares@ €28.34710.0013% mcap5.9% of flow
Common Shares
SEC:0001209191-22-017418:0·
€34,11710,288 shares@ €3.31620.0006% mcap2.8% of flow
Common Shares
SEC:0001209191-22-017341:0·
€480,75317,557 shares@ €27.38240.0091% mcap87.3% of flow
Common Shares
SEC:0001209191-21-064931·
€480,75317,557 shares@ €27.38240.0091% mcap39.9% of flow
Common Shares
SEC:0001209191-21-064931:0·
€69,67122,633 shares@ €3.078312.7% of flow
Common Shares
SEC:0001209191-21-035911·
€69,67122,633 shares@ €3.07830.0013% mcap5.8% of flow
Common Shares
SEC:0001209191-21-035911:0·
6 of 6 declarations
About PIMSTONE SIMON N.
Simon N. Pimstone is the CEO and Director at Xenon Pharmaceuticals Inc. He leads the company in the pharmaceutical sector, focusing on developing innovative treatments. His leadership is essential in guiding the strategy and growth of the company.
